Work

A Phase 1 Study of Moxetumomab Pasudotox, An Anti-CD22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (HCL): Updated Results

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.2516.2516

Authors: Robert J. Kreitman, Martin S. Tallman, Steven Coutre, Tadeusz Robak, Wyndham H. Wilson, Maryalice Stetler-Stevenson, Pierre Noel, David J. FitzGerald, Manuela Buzoianu, Robert J. Lechleider, Ira Pastan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Northwestern University, Stanford Medicine, Stanford University, Medical University of Lodz, National Institutes of Health Clinical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2554923717

FWCI: 1.038

Cites:

Cited by: 8

Related to: 10